Last Updated: July 22, 2026

India Drug Patents

« Back to Dashboard


Drug Patents in India and US Equivalents

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
Patent Number Estimated Expiration Equivalent US Patent US Expiry Date Generic Name US Applicant US Tradename
3377DEN2012 ⤷  Start Trial 10772888 2032-03-30 raltegravir potassium Msd Sub Merck ISENTRESS
3377DEN2012 ⤷  Start Trial 10772888 2032-03-30 raltegravir potassium Msd Sub Merck ISENTRESS HD
42DEN2015 ⤷  Start Trial 11139056 2033-06-05 bupropion hydrochloride; naltrexone hydrochloride Nalpropion CONTRAVE
42DEN2015 ⤷  Start Trial 10403170 2033-06-05 bupropion hydrochloride; naltrexone hydrochloride Nalpropion CONTRAVE
449KON2015 ⤷  Start Trial 10869869 2034-02-28 dabrafenib mesylate Novartis TAFINLAR
449KON2015 ⤷  Start Trial 10869869 2034-02-28 trametinib dimethyl sulfoxide Novartis MEKINIST
6125DEN2014 ⤷  Start Trial 10117844 2033-01-04 omega-3-carboxylic acids Astrazeneca EPANOVA
>Patent Number >Estimated Expiration >Equivalent US Patent >US Expiry Date >Generic Name >US Applicant >US Tradename

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.